{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T00:42:31Z","timestamp":1711845751504},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,29]]},"DOI":"10.7759\/cureus.57227","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T06:05:41Z","timestamp":1711778741000},"source":"Crossref","is-referenced-by-count":0,"title":["Relationship Between COVID-19 and Linezolid-Resistant Enterococci: A Retrospective Single-Center Study"],"prefix":"10.7759","author":[{"given":"Amber","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhil","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogendra","family":"Pal Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Pratap Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchitra","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00058-18","article-title":"The Enterococcus: a model of adaptability to its environment","volume":"32","author":"Garc\u00eda-Solache M","year":"2019","unstructured":"Garc\u00eda-Solache M, Rice LB. The Enterococcus: a model of adaptability to its environment. Clin Microbiol Rev. 2019, 32:10.1128\/CMR.00058-18","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.720647","article-title":"he global prevalence of daptomycin, tigecycline, and linezolid-resistant Enterococcus faecalis and Enterococcus faecium strains from human clinical samples: a systematic review and meta-analysis","volume":"8","author":"Dadashi M","year":"2021","unstructured":"Dadashi M, Sharifian P, Bostanshirin N, et al.. he global prevalence of daptomycin, tigecycline, and linezolid-resistant Enterococcus faecalis and Enterococcus faecium strains from human clinical samples: a systematic review and meta-analysis. Front Med (Lausanne). 2021, 8:720647. 10.3389\/fmed.2021.720647","journal-title":"Front Med (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8081155","article-title":"Mechanisms of linezolid resistance among enterococci of clinical origin in Spain\u2014detection of optrA- and cf.(D)-carrying E. faecalis","volume":"8","author":"Ruiz-Ripa L","year":"2020","unstructured":"Ruiz-Ripa L, Fe\u00dfler AT, Hanke D, et al.. Mechanisms of linezolid resistance among enterococci of clinical origin in Spain\u2014detection of optrA- and cf.(D)-carrying E. faecalis. Microorganisms. 2020, 8:10.3390\/microorganisms8081155","journal-title":"Microorganisms"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2017.10.018","article-title":"The emerging problem of linezolid-resistant enterococci","volume":"13","author":"Bi R","year":"2018","unstructured":"Bi R, Qin T, Fan W, Ma P, Gu B. The emerging problem of linezolid-resistant enterococci. J Glob Antimicrob Resist. 2018, 13:11-9. 10.1016\/j.jgar.2017.10.018","journal-title":"J Glob Antimicrob Resist"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.570650","article-title":"Linezolid resistance in Enterococcus faecalis associated with urinary tract infections of patients in a tertiary hospitals in China: resistance mechanisms, virulence, and risk factors","volume":"9","author":"Ma X","year":"2021","unstructured":"Ma X, Zhang F, Bai B, et al.. Linezolid resistance in Enterococcus faecalis associated with urinary tract infections of patients in a tertiary hospitals in China: resistance mechanisms, virulence, and risk factors. Front Public Health. 2021, 9:570650. 10.3389\/fpubh.2021.570650","journal-title":"Front Public Health"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijmr.2020.021","article-title":"Linezolid resistant Enterococcus faecium in sepsis","volume":"7","author":"Samantaray S","year":"2020","unstructured":"Samantaray S, Deepashree, Cherian A, Anitha, Sastry A. Linezolid resistant Enterococcus faecium in sepsis. Indian J Microbiol Res. 2020, 7:99-103. 10.18231\/j.ijmr.2020.021","journal-title":"Indian J Microbiol Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-021-02773-2","article-title":"Prevalence of linezolid-resistant organisms among patients admitted to a tertiary hospital for critical care or dialysis","volume":"191","author":"Dembicka KM","year":"2022","unstructured":"Dembicka KM, Powell J, O'Connell NH, Hennessy N, Brennan G, Dunne CP. Prevalence of linezolid-resistant organisms among patients admitted to a tertiary hospital for critical care or dialysis. Ir J Med Sci. 2022, 191:1745-50. 10.1007\/s11845-021-02773-2","journal-title":"Ir J Med Sci"},{"key":"ref8","article-title":"Emergence of linezolid resistance in Enterococci- prevalent genotype and resistance pattern in vancomycin-resistant enterococci in North-Indian tertiary care hospital","volume":"74","author":"Sami H","year":"2020","unstructured":"Sami H, Singh A, Ahmed S, Shahid M. Emergence of linezolid resistance in Enterococci- prevalent genotype and resistance pattern in vancomycin-resistant enterococci in North-Indian tertiary care hospital. NZJ Lab Sci. 2020, 74:27-30.","journal-title":"NZJ Lab Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/2231-0770.127416","article-title":"The first linezolid-resistant Enterococcus faecium in India: High level resistance in a patient with no previous antibiotic exposure","volume":"4","author":"Kumar S","year":"2014","unstructured":"Kumar S, Bandyoapdhyay M, Chatterjee M, Mukhopadhyay P, Poddar S, Banerjee P. The first linezolid-resistant Enterococcus faecium in India: High level resistance in a patient with no previous antibiotic exposure. Avicenna J Med. 2014, 4:13-6. 10.4103\/2231-0770.127416","journal-title":"Avicenna J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(03)00153-6","article-title":"Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs","volume":"47","author":"Ruggero KA","year":"2003","unstructured":"Ruggero KA, Schroeder LK, Schreckenberger PC, Mankin AS, Quinn JP. Nosocomial superinfections due to linezolid-resistant Enterococcus faecalis: evidence for a gene dosage effect on linezolid MICs. Diagn Microbiol Infect Dis. 2003, 47:511-3. 10.1016\/S0732-8893(03)00153-6","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa075","article-title":"Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds","volume":"75","author":"Egan SA","year":"2020","unstructured":"Egan SA, Shore AC, O'Connell B, Brennan GI, Coleman DC. Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds. J Antimicrob Chemother. 2020, 75:1704-11. 10.1093\/jac\/dkaa075","journal-title":"J Antimicrob Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00138-7","article-title":"COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion","volume":"9","author":"van de Veerdonk FL","year":"2021","unstructured":"van de Veerdonk FL, Br\u00fcggemann RJ, Vos S, et al.. COVID-19-associated Aspergillus tracheobronchitis: the interplay between viral tropism, host defence, and fungal invasion. Lancet Respir Med. 2021, 9:795-802. 10.1016\/S2213-2600(21)00138-7","journal-title":"Lancet Respir Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China","volume":"185","author":"Song G","year":"2020","unstructured":"Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020, 185:599-606. 10.1007\/s11046-020-00462-9","journal-title":"Mycopathologia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/jhm.994","article-title":"Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin","volume":"7","author":"Twilla JD","year":"2012","unstructured":"Twilla JD, Finch CK, Usery JB, Gelfand MS, Hudson JQ, Broyles JE. Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin. J Hosp Med. 2012, 7:243-8. 10.1002\/jhm.994","journal-title":"J Hosp Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ph3071988","article-title":"Linezolid resistance in Staphylococci","volume":"3","author":"Stefani S","year":"2010","unstructured":"Stefani S, Bongiorno D, Mongelli G, Campanile F. Linezolid resistance in Staphylococci. Pharmaceuticals (Basel). 2010, 3:1988-2006. 10.3390\/ph3071988","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1086\/659152","article-title":"Emergence of daptomycin-resistant VRE: experience of a single institution","volume":"32","author":"Kamboj M","year":"2011","unstructured":"Kamboj M, Cohen N, Gilhuley K, Babady NE, Seo SK, Sepkowitz KA. Emergence of daptomycin-resistant VRE: experience of a single institution. Infect Control Hosp Epidemiol. 2011, 32:391-4. 10.1086\/659152","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2018.10.002","article-title":"Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature","volume":"40","author":"Bender JK","year":"2018","unstructured":"Bender JK, Cattoir V, Hegstad K, et al.. Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature. Drug Resist Updat. 2018, 40:25-39. 10.1016\/j.drup.2018.10.002","journal-title":"Drug Resist Updat"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02803-15","article-title":"Linezolid surveillance results for the United States (LEADER Surveillance Program 2014)","volume":"60","author":"Flamm RK","year":"2016","unstructured":"Flamm RK, Mendes RE, Hogan PA, Streit JM, Ross JE, Jones RN. Linezolid surveillance results for the United States (LEADER Surveillance Program 2014). Antimicrob Agents Chemother. 2016, 60:2273-80. 10.1128\/AAC.02803-15","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12399","article-title":"The risk\/benefit of predicting a post-antibiotic era: is the alarm working?","volume":"1323","author":"Fowler T","year":"2014","unstructured":"Fowler T, Walker D, Davies SC. The risk\/benefit of predicting a post-antibiotic era: is the alarm working?. Ann N Y Acad Sci. 2014, 1323:1-10. 10.1111\/nyas.12399","journal-title":"Ann N Y Acad Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0885066618762747","article-title":"Antibiotic use in the intensive care unit: optimization and de-escalation","volume":"33","author":"Campion M","year":"2018","unstructured":"Campion M, Scully G. Antibiotic use in the intensive care unit: optimization and de-escalation. J Intensive Care Med. 2018, 33:647-55. 10.1177\/0885066618762747","journal-title":"J Intensive Care Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn043","article-title":"An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit","volume":"61","author":"Kelly S","year":"2008","unstructured":"Kelly S, Collins J, Maguire M, Gowing C, Flanagan M, Donnelly M, Murphy PG. An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit. J Antimicrob Chemother. 2008, 61:901-7. 10.1093\/jac\/dkn043","journal-title":"J Antimicrob Chemother"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx292","article-title":"Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE","volume":"72","author":"Lazaris A","year":"2017","unstructured":"Lazaris A, Coleman DC, Kearns AM, et al.. Novel multiresistance cfr plasmids in linezolid-resistant methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (VRE) from a hospital outbreak: co-location of cfr and optrA in VRE. J Antimicrob Chemother. 2017, 72:3252-7. 10.1093\/jac\/dkx292","journal-title":"J Antimicrob Chemother"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10020219","article-title":"Spread of linezolid-resistant Enterococcus spp. in human clinical isolates in the Czech Republic","volume":"10","author":"Mali\u0161ov\u00e1 L","year":"2021","unstructured":"Mali\u0161ov\u00e1 L, Jakub\u016f V, Pomorsk\u00e1 K, Mus\u00edlek M, \u017demli\u010dkov\u00e1 H. Spread of linezolid-resistant Enterococcus spp. in human clinical isolates in the Czech Republic. Antibiotics (Basel). 2021, 10:10.3390\/antibiotics10020219","journal-title":"Antibiotics (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2015.02.007","article-title":"Increased frequency of linezolid resistance among clinical Enterococcus faecium isolates from German hospital patients","volume":"3","author":"Klare I","year":"2015","unstructured":"Klare I, Fleige C, Geringer U, et al.. Increased frequency of linezolid resistance among clinical Enterococcus faecium isolates from German hospital patients. J Glob Antimicrob Resist. 2015, 3:128-31. 10.1016\/j.jgar.2015.02.007","journal-title":"J Glob Antimicrob Resist"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105977","article-title":"Interregional spread in Spain of linezolid-resistant Enterococcus spp. isolates carrying the optrA and poxtA genes","volume":"55","author":"Moure Z","year":"2020","unstructured":"Moure Z, Lara N, Mar\u00edn M, et al.. Interregional spread in Spain of linezolid-resistant Enterococcus spp. isolates carrying the optrA and poxtA genes. Int J Antimicrob Agents. 2020, 55:105977. 10.1016\/j.ijantimicag.2020.105977","journal-title":"Int J Antimicrob Agents"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/224352-relationship-between-covid-19-and-linezolid-resistant-enterococci-a-retrospective-single-center-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T06:05:44Z","timestamp":1711778744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/224352-relationship-between-covid-19-and-linezolid-resistant-enterococci-a-retrospective-single-center-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.57227","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,29]]}}}